Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 111 results for "harvard bone marrow initiative"

Axsome Therapeutics Initiates Phase 3 Study of AXS-05 for Trea...

First Patient Enrolled in the STRIDE-1 Study Second Product Candidate Axsome Has Advanced into a Pivotal Trial NEW YORK, March 17, 2016 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company ... 4 Traders, 1 month ago
[x]  

The Cancer Industry Exposed In Less Than 2000 Words

(Before It's News)An Exclusive You Have To See: Facebook's Diabolical New Initiative Is Causing Mass Exodus—1000s Shut Down As They Discover… by Arjun Walia, Collective Evolution It's hard to believe that approximately one in every two people ...
 Before It's News1 month ago

Full Show: Preventing Myeloma Before it Gets Started with Dr. Irene Ghobrial, MD, Dana Farber Cancer Institue

Dr. Irene Ghobrial, MD Dana Farber Cancer Institute / Harvard School of Medicine Interview Date: March 17, 2016 Summary Can we prevent smoldering myeloma or MGUS from progressing to active myeloma? Dr. Irene Ghobrial, MD wonders why we are ...
 Myeloma Crowd1 month ago Full Show: Achieving Minimal Residual Disease with Myeloma Vaccines with Dr. David Avigan, MD Beth Israel Deaconess Medical Center  Myeloma Crowd1 month ago

Identifying drug targets for leukaemia

Researchers from Hong Kong and the U.S. have developed a new statistical and mapping method that could help identify drug targets for treating leukaemia. In chronic myelogenous leukaemia (CML), too many stem cells in the bone marrow are ...
 Innovations Report2 days ago

10 Things Every Woman Should Know About Maintaining Healthy Bones

When it comes to protecting your body's 206 bones, it's never too early to start, says Abby Abelson, MD, chair of the department of rheumatic and immunologic diseases at the Cleveland Clinic. "Many women don't even think about their bones until they ...
 ABC News4 days ago

Aduro Biotech Reports Publishing of Key Preclinical Data Highlighting New Approach to Treat Multiple Myeloma

Aduro Biotech, Inc. (Nasdaq: ADRO ) today announced the publication of a pivotal paper elucidating the roles of B cell maturation antigen (BCMA) and its ligand A PRoliferation-Inducing Ligand (APRIL) in multiple myeloma, highlighting the potential ...
 Morningstar.com6 days ago Aduro Biotech Announces Key Preclinical Data Published Highlighting New Approach to Treat Multiple Myeloma  4 Traders6 days ago
[x]  

AbbVie Receives FDA Accelerated Approval of Venclexta venetoclax Tablets, the First BCL-2 Inhibitor in Relapsed/Refractory Chronic Lymphocytic...

AbbVie Receives FDA Accelerated Approval of Venclexta venetoclax Tablets, the First BCL-2 Inhibitor in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients with 17p Deletion By a News Reporter-Staff News Editor at Politics & Government ...
 Pharmacy Choice6 days ago 4/28/16 - AbbVie Receives FDA Accelerated Approval of Venclexta venetoclax Tablets, the First BCL-2 Inhibitor in Relapsed/Refractory Chronic Lymphocytic...  Pharmacy Choice6 days ago 4/12/16 - AbbVie Receives FDA Accelerated Approval of Venclexta?¢ (venetoclax) Tablets, the First BCL-2 Inhibitor in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients with 17p Deletion  Pharmacy Choice3 weeks ago 4/11/16 - AbbVie Receives FDA Accelerated Approval of Venclexta?¢ (venetoclax) Tablets, the First BCL-2 Inhibitor in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients with 17p Deletion  Pharmacy Choice3 weeks ago
[x]  

Micrometastatic Disease in Ewing Sarcoma

1 , Jeremy V. Edwards 2 , C. Lorrie Epling 3 , Elizabeth Sinclair 3 , Douglas S. Hawkins 4 , Holcombe E. Grier 5 , Katherine A. Janeway 5 , Phillip Barnette 6 , Elizabeth McIlvaine 7 , Mark D. Krailo 7 , Donald A. Barkauskas 7 , Katherine ...
 Clinical Cancer Research1 week ago

Fred Hutch leader Gary Gilliland elected to American Academy of Arts and Sciences

EurekAlert! provides embargoed and breaking science news you can't afford to miss. EurekAlert! offers a one-stop science news distribution service you can trust. EurekAlert! is a service of the American Association for the Advancement of Science. ...
 EurekAlert!2 weeks ago Ten Researchers to Receive Heinz Maier-Leibnitz Prizes  Alpha Galileo4 weeks ago
PRWeb

Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study April 20, 2016The Reanima Project - Is Death Reversible?

With the convergence of the disciplines of regenerative biology, cognitive neuroscience, and clinical resuscitation, we are poised to delve into an area of scientific understanding previously inaccessible with existing technologies. - Ira S. Pastor, ...
 PRWeb2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - harvard bone marrow initiative
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less